770-25-3-801-0438 -National CMOP F0608: FERROUS SULFATE 324MG EC TAB

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is preparing to issue a Request for Quotation (RFQ 36C77025Q0233) for Ferrous Sulfate 324mg EC Tablets, which falls under the Pharmaceutical Preparation Manufacturing NAICS category. This pre-solicitation notice indicates the government's intent to procure pharmaceutical products, specifically targeting the manufacture and supply of ferrous sulfate tablets for veterans' healthcare facilities. The solicitation is classified under the Drugs and Biologicals Product Service Code (6505-P), suggesting a specialized medical supply procurement. While specific evaluation criteria are not fully detailed in the pre-solicitation notice, typical pharmaceutical contract assessments often include factors such as manufacturing capabilities, quality control processes, pricing, and delivery reliability. The critical dates for this opportunity include a posting date of May 15, 2025, with responses due by May 22, 2025, providing a relatively short response window of approximately one week.

The pre-solicitation notice does not indicate any specific set-aside designations, meaning the opportunity appears open to all qualified manufacturers. No incumbent contractor information is provided in the available documentation. As a pharmaceutical contract for the Veterans Health Administration, the procurement likely represents a significant volume requirement to support healthcare services across Veterans Integrated Service Network 15's region. The specific quantity of Ferrous Sulfate 324mg EC Tablets is not explicitly stated in the pre-solicitation notice, which suggests potential vendors should be prepared to discuss scalable manufacturing capabilities. The contract appears to be part of a standardized medical supply chain procurement process, typical of large-scale federal healthcare system acquisitions, with the potential for multiple-award or extended contract possibilities.